Akzo Nobel India's stock price took a hit, falling over 11% after its promoter, Imperial Chemical Industries, sold a significant stake in the company. However, in a surprising move, Goldman Sachs picked up shares worth Rs 106 crore, sparking curiosity among investors.
What Happened?
Goldman Sachs purchased 3.36 lakh shares in Akzo Nobel India via its affiliate, Goldman Sachs Funds-Goldman Sachs India Equity Portfolio, at a price of Rs 3,150 apiece. This was part of a larger stake sale by the promoter, which sold nearly 41 lakh shares valued at Rs 1,296 crore.
Impact on the Stock
The development led to a sharp decline in Akzo Nobel's stock price, despite the involvement of a prominent buyer like Goldman Sachs. As of September 30, 2025, the promoter held a 45.46% stake in the company, and the latest transaction represents a substantial reduction in its holdings.
Company Performance
Akzo Nobel India reported a Profit After Tax (PAT) of Rs 1,682.7 crore for the second quarter of FY2025-26, a significant increase from Rs 75.8 crore in the corresponding period last year. However, revenue from operations declined by 1.5% year-on-year to Rs 834.9 crore, and operating performance also moderated, with Earnings Before Interest and Tax (EBIT) down 2.4% to Rs 92.3 crore.
Key Points to Consider
- Growth in PAT was driven by one-time gains
- Revenue from operations declined due to the divestment of certain businesses
- Operating performance was affected by the decline in revenue
Remember, this is a perspective on the current situation, and it's essential to do your own research before making any investment decisions. The stock market can be unpredictable, and it's crucial to stay informed and up-to-date on the latest developments.